Development and feasibility of an mHealth intervention for psychoeducational support of Nigerian women diagnosed with breast cancer undergoing chemotherapy: A pilot randomized controlled trial

Development of a Mobile Health Support Program for Nigerian Women with Breast Cancer

Background

Breast cancer (BC) is a major health issue worldwide, particularly in Nigeria, where it has high rates of occurrence and death. Chemotherapy, a common treatment, can cause physical and emotional challenges that affect patients’ quality of life. There is a need for mobile health (mHealth) solutions to provide support, but little research exists on their use among Nigerian women with BC.

Objective

The aim of this study was to create and test an mHealth program called the ChEmo Nurse Breast cancer Application (CENBA) to see if it could be easily used and accepted by patients.

Methods

This pilot study was conducted at two hospitals in Lagos. Thirty women who were newly diagnosed with BC and undergoing chemotherapy were randomly divided into two groups: one received the CENBA program, which included education about BC, coping skills training, a discussion forum, and consultations with nurses through a mobile app and phone calls over six weeks. The other group received standard care. We measured the program’s feasibility by looking at consent, dropout rates, and completion rates, and we explored acceptability through interviews.

Results

The completion rate of the study was 93.3%. Feedback from participants showed they found the program helpful, especially the educational materials and emotional support from the discussion forum and nurse consultations.

Conclusion

The CENBA program proved to be a practical and acceptable mHealth option for providing psychoeducational support to Nigerian women undergoing chemotherapy for BC. These results suggest that this program could be an effective tool to meet the needs of these patients and should be further explored in a larger trial.

Trial Registration

This study is a preliminary feasibility investigation for a larger trial, which is registered in the United States Clinical Trials registry (number NCT05489354).

Clinical Trials and AI in Healthcare

Clinical trials are essential for developing safe and effective treatments. Our AI-powered platform, DocSym, integrates clinical guidelines and research into a single resource for healthcare providers.

In today’s healthcare landscape, efficiency is key. Our mobile applications assist with scheduling, treatment monitoring, and telemedicine, simplifying patient care and expanding digital services.

By leveraging AI, clinics can optimize their workflows, enhance patient outcomes, and reduce paperwork. Discover how we can assist you at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.